Traws Pharma, Inc. ( TRAW) - Key Metrics
TRAW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.67 | -$0.24 | -$0.24 |
| 2025Q4 | $0 | -$0.90 | -$0.34 | -$0.34 |
| 2025Q2 | $0.47 | -$0.16 | -$1.03 | -$1.03 |
| 2025Q1 | $0.01 | $2.17 | -$0.78 | -$0.78 |
| 2024Q4 | $0.06 | -$8.81 | -$4.20 | -$4.20 |
TRAW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.86 |
| 2025Q4 | 0% | -0.83 |
| 2025Q2 | 0% | -3.36 |
| 2025Q1 | ? | 0.27 |
| 2024Q4 | 0% | -0.25 |
TRAW
Price: $0.37
52 week price:
Earnings Per Share: -1.83 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.9 million